Literature DB >> 9527016

Complement depletion improves neurological function in cerebral ischemia.

U S Vasthare1, F C Barone, H M Sarau, R H Rosenwasser, M DiMartino, W F Young, R F Tuma.   

Abstract

The contribution of the complement system to the exacerbation of cerebral ischemia/reperfusion injury was studied by comparing a group of rats with normal complement levels to another group that was complement depleted by cobra venom factor (CVF). The magnitude of reactive hyperemia was significantly greater in the complement depleted animals. There was also better preservation of somatosensory evoked potentials (SSEPs) in the complement depleted animals. These differences were not associated with changes in leukocyte infiltration as evidenced by myeloperoxidase and Leukotriene B4 activity. These data demonstrate that depleting the complement system can improve flow and outcome following cerebral ischemia with reperfusion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9527016     DOI: 10.1016/s0361-9230(97)00408-5

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  15 in total

1.  A simple, yet highly accurate, QSAR model captures the complement inhibitory activity of compstatin.

Authors:  Chandrika Mulakala; John D Lambris; Yiannis Kaznessis
Journal:  Bioorg Med Chem       Date:  2006-12-13       Impact factor: 3.641

Review 2.  Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.

Authors:  T V Arumugam; T M Woodruff; J D Lathia; P K Selvaraj; M P Mattson; S M Taylor
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

Review 3.  Complement inhibition as a proposed neuroprotective strategy following cardiac arrest.

Authors:  Brad E Zacharia; Zachary L Hickman; Bartosz T Grobelny; Peter A DeRosa; Andrew F Ducruet; E Sander Connolly
Journal:  Mediators Inflamm       Date:  2010-01-26       Impact factor: 4.711

4.  The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q.

Authors:  Maria Grazia De Simoni; Emanuela Rossi; Claudio Storini; Simone Pizzimenti; Cinara Echart; Luigi Bergamaschini
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

5.  Systemic complement activation following human acute ischaemic stroke.

Authors:  E D Pedersen; U Waje-Andreassen; C A Vedeler; G Aamodt; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

6.  Synergistic neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhage.

Authors:  Matthew C Garrett; Marc L Otten; Robert M Starke; Ricardo J Komotar; Paola Magotti; John D Lambris; Michal A Rynkowski; E Sander Connolly
Journal:  Brain Res       Date:  2009-05-04       Impact factor: 3.252

Review 7.  Aberrant Complement System Activation in Neurological Disorders.

Authors:  Karolina Ziabska; Malgorzata Ziemka-Nalecz; Paulina Pawelec; Joanna Sypecka; Teresa Zalewska
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

8.  Low ficolin-3 levels in early follow-up serum samples are associated with the severity and unfavorable outcome of acute ischemic stroke.

Authors:  George Füst; Lea Munthe-Fog; Zsolt Illes; Gábor Széplaki; Tihamér Molnar; Gabriella Pusch; Kristóf Hirschberg; Robert Szegedi; Zoltán Széplaki; Zoltán Prohászka; Mikkel-Ole Skjoedt; Peter Garred
Journal:  J Neuroinflammation       Date:  2011-12-29       Impact factor: 8.322

Review 9.  New insights of an old defense system: structure, function, and clinical relevance of the complement system.

Authors:  Christian Ehrnthaller; Anita Ignatius; Florian Gebhard; Markus Huber-Lang
Journal:  Mol Med       Date:  2010-10-29       Impact factor: 6.354

Review 10.  Influence of inflammation on poststroke plasticity.

Authors:  Monika Liguz-Lecznar; Malgorzata Kossut
Journal:  Neural Plast       Date:  2013-02-21       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.